Rebinyn Kit
Product Images NDC 0169-7905

Product Visual Gallery

This gallery contains 38 technical images submitted to the FDA as part of the official labeling for Rebinyn (NDC 0169-7905). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Novo Nordisk, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Overview Of Rebinyn Package (Image 01)

An instructional illustration depicting the components of a REBINYN kit by Novo Nordisk. It shows a vial with REBINYN powder sealed with a plastic cap and rubber stopper, a vial adapter with protective cap and spike, a pre-filled syringe containing histidine diluent with a syringe tip, scale markings, rubber plunger, and syringe cap, and a plunger rod with a wide top end and thread.*

FDA Label Image

Symbol (Image 02)

FDA Label Image

Vial Adapter (Image 04)

An instructional diagram showing a vial adapter with labeled parts including a protective cap, a spike under protective paper, and the protective paper itself. The image appears to guide the user on the components of the vial adapter included in the REBINYN kit by Novo Nordisk.*

FDA Label Image

Fig. A (Image 05)

An instructional illustration showing two hands holding medical devices, suggesting preparation or assembly steps for the REBINYN kit. The left hand holds a device with a plunger or stopper, and the right hand holds a vial or similar container, indicating a typical step in drug reconstitution or administration preparation.*

FDA Label Image

Fig. B (Image 06)

Illustration showing a hand holding a vial with the thumb removing or lifting the cap upwards. This instructional image is part of a kit, presumably demonstrating how to open or prepare the vial for use.*

FDA Label Image

Fig. C (Image 07)

Instructional illustration showing a step in the use of REBINYN coagulation factor IX recombinant, GlycoPEGylated kit. The image depicts two hands, one holding a cap and the other pulling or lifting a clear blister or container with an upward arrow indicating removal or detachment.*

FDA Label Image

Fig. D (Image 08)

An instructional illustration showing a hand pressing down on a flip-off cap to remove it from a vial, indicated by a downward arrow, demonstrating vial preparation steps for use with REBINYN coagulation factor IX recombinant, GlycoPEGylated kit from Novo Nordisk.*

FDA Label Image

Fig. E (Image 09)

Illustration showing a hand gripping the top of a vial to remove a cap or seal. The image includes an upward arrow indicating the direction to pull, with a smaller inset showing a full vial with a cap in place, suggesting part of a medication preparation or administration process for the product kit.*

FDA Label Image

Fig. F (Image 10)

An instructional illustration showing two hands holding a syringe-like device, with an arrow indicating a twisting motion on the plunger. The image appears to be part of a step-by-step guide, likely demonstrating how to use or prepare the device in a REBINYN coagulation factor IX recombinant, GlycoPEGylated kit.*

FDA Label Image

Fig. G (Image 11)

An instructional illustration showing a pair of hands preparing a vial by removing a cap or lid, depicting a step in the process of using a medication kit. The image is labeled with the letter 'G' in the top left corner, part of a sequence likely for the REBINYN (coagulation factor IX recombinant, GlycoPEGylated) kit by Novo Nordisk.*

FDA Label Image

Fig. H (Image 12)

An instructional illustration showing hands assembling or connecting two components, likely part of the REBINYN kit for preparation before use. The image uses arrows to indicate the twisting or attachment action needed to join the parts securely, as part of the medication administration process.*

FDA Label Image

Fig. I (Image 13)

An instructional illustration depicting a hand holding a syringe-like device, with an arrow pointing to a part of the device, likely indicating a step in the preparation or administration process. The image is related to the REBINYN kit, a human prescription drug containing coagulation factor IX recombinant, GlycoPEGylated, by Novo Nordisk.*

FDA Label Image

Fig. J (Image 14)

An instructional illustration showing a hand holding a syringe vertically with the needle end down, positioned above a vial. A circular arrow around the vial indicates a rotation or stirring motion, suggesting mixing or reconstitution of the medication.*

FDA Label Image

Fig. K (Image 15)

An instructional illustration showing a hand holding a syringe vertically with the needle cap attached. A downward arrow indicates pushing the syringe plunger downwards, likely part of the preparation or administration steps for the REBINYN kit.*

FDA Label Image

Pre-filled Syringe With Histidine Diluent (Image 16)

An instructional illustration of a pre-filled syringe with histidine diluent from the REBINYN kit. The diagram labels the syringe tip under the syringe cap, the scale on the barrel, the rubber plunger, and the syringe cap itself, showing components involved in drug administration.*

FDA Label Image

Plunger Rod (Image 17)

An illustration diagram showing a plunger rod with labeled parts including a threaded end and a wide top end. This component is likely part of the packaging or administration kit for REBINYN (coagulation factor IX recombinant, GlycoPEGylated) by Novo Nordisk.*

FDA Label Image

Fig. A (Image 18)

An instructional illustration showing hands holding two small vials or syringes, likely part of a medication preparation step for a kit. The left hand holds a vial with a plunger, and the right hand holds a vial with a blue cap, indicating an initial step in assembling or mixing drug components.*

FDA Label Image

Fig. B (Image 19)

Instructional illustration showing a hand gripping a vial and lifting or removing its cap by pulling upwards. This image is part of the REBINYN kit usage instructions.*

FDA Label Image

Fig. C (Image 20)

An instructional illustration depicting hands removing the top seal from a small vial or container by lifting it upward, indicated by a blue arrow. This step is likely part of the preparation process for REBINYN (coagulation factor IX recombinant, GlycoPEGylated) kit by Novo Nordisk.*

FDA Label Image

Fig. D (Image 21)

An instructional illustration showing a hand pressing down on a plastic cap above a vial, with a downward arrow indicating the cap is to be pushed onto the vial. This is part of usage directions, likely for assembling or preparing the REBINYN kit containing coagulation factor IX recombinant.*

FDA Label Image

Fig. E (Image 22)

Instructional illustration showing a hand lifting a cap off a vial, demonstrating a step in the preparation of REBINYN (coagulation factor IX recombinant, GlycoPEGylated) kit for use. An arrow indicates the direction to remove the cap from the vial.*

FDA Label Image

Fig. F (Image 23)

Instructional diagram showing hands holding and twisting a syringe plunger, indicated by an arrow representing the direction to twist. Part of a medication administration guide for the REBINYN coagulation factor IX recombinant, GlycoPEGylated kit by Novo Nordisk.*

FDA Label Image

Fig. G (Image 24)

An instructional illustration showing two hands connecting or attaching two medical device components, likely part of a medication preparation or administration kit. One hand holds a small cylindrical piece, and the other hand holds a square or rectangular piece with an arrow indicating the joining direction.*

FDA Label Image

Fig. H (Image 25)

An instructional illustration showing two hands twisting a capped syringe or pen-like device to attach or remove its cap, indicated by a curved arrow. The background is light purple with a white section, and there is a blue square with the letter 'H' in the top left corner.*

FDA Label Image

Fig. I (Image 26)

An instructional diagram showing a hand holding a syringe, with a blue arrow indicating a step in preparation or assembly. The image is part of a set likely illustrating usage or administration steps for the REBINYN coagulation factor IX recombinant, GlycoPEGylated kit by Novo Nordisk.*

FDA Label Image

Fig. J (Image 27)

Illustration showing a hand holding a syringe above a vial, with an arrow indicating the direction to twist or attach the syringe to the vial. This image likely depicts a step in preparing or assembling a medication from a kit.*

FDA Label Image

Symbol (Image 28)

FDA Label Image

Fig. K (Image 29)

An instructional illustration showing a hand holding a syringe, with a downward arrow indicating a push or plunger movement. The background is shaded blue with a small 'K' in the top left corner. This image likely relates to the administration or preparation of the REBINYN coagulation factor IX recombinant, GlycoPEGylated kit by Novo Nordisk.*

FDA Label Image

Fig. L (Image 30)

An instructional diagram showing hands connecting two components, likely part of the REBINYN kit assembly process. The image includes an arrow indicating the direction to attach the parts, suggesting it is guidance for proper kit use or preparation.*

FDA Label Image

Fig. M (Image 31)

Instructional diagram showing a step in the preparation or administration process involving a vial with a septum, a syringe with a needle, and a small vial or container. The image depicts the action of inserting the needle into the vial through a marked septum with a curved arrow indicating movement.*

FDA Label Image

1000 Iu Carton (Image 32)

Packaging label for REBINYN 500 IU Range kit, containing coagulation factor IX (recombinant), GlycoPEGylated. The label shows the kit dosage form with a vial and pre-filled diluent syringe. It is labeled for intravenous use, single-dose, and prescription only. The labeler is Novo Nordisk.*

FDA Label Image

2000 Iu Carton (Image 33)

REBINYN 1000 IU Range kit packaging label for coagulation factor IX recombinant, GlycoPEGylated by Novo Nordisk. The kit contains a 1000 IU single-dose vial of the product and a pre-filled diluent syringe with an attached MixPro adapter. Label text includes usage instructions for intravenous use after reconstitution and notes no preservatives included.*

FDA Label Image

Histidine Solution (Image 34)

Label for REBINYN 500 IU Range, coagulation factor IX recombinant, GlycoPEGylated. The label indicates storage instructions to keep in a refrigerator at 36°F - 46°F (2°C - 8°C) and not to freeze. It specifies reconstitution with 4 mL histidine diluent only. Labeler is Novo Nordisk Inc., and a contact number 1-844-REB-INYN is provided. The label includes the NDC number 0169-7955-11.*

FDA Label Image

500 Iu Carton (Image 35)

Packaging label for REBINYN 2000 IU Range kit by Novo Nordisk. The product contains coagulation factor IX (recombinant), GlycoPEGylated, 2000 IU. The label includes usage instructions for intravenous administration after reconstitution, specifies single-dose use with discard of unused portions, and notes the inclusion of a MixPro vial adapter and pre-filled diluent syringe. Branding elements feature the REBINYN name, dosage strength, and a syringe and vial illustration.*

FDA Label Image

500 Iu Vial (Image 36)

REBINYN 1000 IU range kit label showing coagulation factor IX (recombinant), GlycoPEGylated. The label includes storage instructions to refrigerate at 36°F-46°F (2°C-8°C) and warns not to freeze. It indicates reconstitution with 4 mL histidine diluent only. Manufactured by Novo Nordisk Inc., with contact information and an NDC (0169-7911-11).*

FDA Label Image

Vial With Rebinyn Powder (Image 37)

Illustration of a vial containing Rebinyn powder, showing a plastic cap on top and a rubber stopper underneath the plastic cap. The vial is part of the REBINYN kit by Novo Nordisk containing coagulation factor IX recombinant, GlycoPEGylated.*

FDA Label Image

Image 38

REBINYN 2000 IU Range kit label, containing Coagulation Factor IX (Recombinant), GlycoPEGylated. The label indicates storage in a refrigerator at 36°F to 46°F (2°C to 8°C) and warns not to freeze. It specifies reconstitution with 4 mL histidine diluent only and is labeled for prescription use only. The product is manufactured by Novo Nordisk.*

FDA Label Image

1000 Iu Vial (Image 39)

Label for Histidine (10 mM Solution) 4 mL for reconstitution of REBINYN, a coagulation factor IX recombinant, GlycoPEGylated. The label includes storage instructions to keep refrigerated between 36°F to 46°F (2°C to 8°C), a single-use note, and a barcode. Manufactured by Novo Nordisk Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.